ClinicalTrials.gg
Sign In
RecruitingNCT06477900PREDIABCOACHUpdated Mar 19, 2026

Impact of SMS Reminder on Weight Loss, as Part of a Health Pathway in Patients With Prediabetes (PREDIABCOACH)

An interventional study of SMS reception in PreDiabetes, sponsored by Centre Hospitalier Universitaire de la Réunion. Recruiting at 2 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by Centre Hospitalier Universitaire de la Réunion · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this interventionnal study is to demonstrate that sending SMS messages with advice on physical activity or nutrition, in addition to a program of hygienic-dietary management, significantly increases weight loss in subjects with prediabetes in La Réunion.

Indeed, type 2 diabetes is a priority health problem on Reunion Island: 10% of the population are treated for type 2 diabetes, twice as many as in France.

International studies have demonstrated the value of modifying dietary and physical activity habits to reduce the risk of transition to diabetes in patients with prediabetes Against this backdrop, a Regional Nutrition Diabetes Program (PRND) 2020-2023 was launched by Réunion's Regional Health Agency (ARS) in 2020.

Studies have also demonstrated the effectiveness of using SMS to encourage and support weight loss interventions.

So, the main question it aims to answer are:

  • Does the addition of 72 SMS of physical activity and nutriton advice, to the "FindRisc Péi-CPTS" program, significantly increase weight loss by 3% after 6 months of starting the program.

FindRiscPei-CPTS program includes sports sessions, dietary consultations and therapeutic education.

The 300 participants will be randomized into two arms

  • 150 participants will take part in the FindRiscPei-CPTS program + receive SMS messages
  • 150 participants will only take part in the FindRiscPei-CPTS program (no SMS)

All participants will follow procedures below:

  • Inclusion: assessment of weight and waist circumference, Lifestyle Questionnaire and Socio-Efficacy Questionnaire.
  • Participation in Findrisk program for 3 to 9 months (+ SMS for experimental group)
  • 3 follow-up visits: 3 months, 6 months and 9 months after starting the program: weight and waist measurement, self-efficacy questionnaire.
Read the detailed description

The outcomes of this study are :

  • A better understanding of the effectiveness of the SMS intervention in the context of health and diet prevention programs for patients with pre-diabetes.
  • More precise recommendations for healthcare professionals and decision-makers on the use of SMS intervention in this context.
  • Improved health outcomes for prediabetes patients through the identification of effective diabetes prevention strategies.
  • A positive impact on healthcare costs by reducing the progression from prediabetes to diabetes, and by reducing the use of costly healthcare associated with diabetes.
02

Conditions studied

  • PreDiabetes

Browse trials for

03

In context

Prediabetic State

918 studies on the registry are indexed under Prediabetic State; 232 are open to participants now.

This study's planned enrollment of 300 is above the median of 62 across 762 interventional studies indexed under Prediabetic State.

Browse Prediabetic State studies →

Lead sponsor

Centre Hospitalier Universitaire de la Réunion is the lead sponsor of 141 studies on the registry; 37 are open to participants now.

Browse Centre Hospitalier Universitaire de la Réunion studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject with prediabetes as defined by HAS (fasting blood glucose > 1.10g/L and \< 1.26g/L; or blood glucose 2h after ingestion of 10g of glucose > 1.40g/L and \< 2g/L [HGPO test])
  • included in a health and diet care program for patients with pre-diabetes offered by one of Réunion's CPTS (FindRisc Péi-CPTS program)
  • age > 18 years
  • in possession of an SMS-enabled telephone
  • able to complete self-efficacy questionnaires
  • not expected to move within 12 months

Exclusion criteria

Exclusion Criteria:

  • participant currently being monitored in the PREDIABRUN study
  • protected adults (under guardianship or curatorship)
  • pregnant women
  • refusal to participate in the study
  • patients unable to speak Creole or French
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    SMS receiption

    150 participants will follow the FindRiscPei-CPTM program (current care) and will also receive 72 SMS messages over 6 months encouraging them to take part in sports and offering nutritional advice.

    Other: SMS reception

  • No intervention
    No SMS

    150 participants will only follow the FindRiscPei-CPTM program (current care) and will not receive SMS.

Interventions

  • OtherSMS reception

    reception of 72 SMS encouraging physical activity and nutritional advice

06

What researchers measure

Primary outcomes

  1. Weight loss > 3%

    Proportion of patients with weight loss greater than or equal to 3% at T1+6 months (comparison between FindRisc Pei-CPTS program + SMS intervention versus FindRisc Pei-CPTS program alone).

    Time frame: 6 month

07

Study locations

1 of 2 sites recruiting
  • Communauté Professionnelle Territoriale de Santé (CPTS RéSO)
    Saint-Louis, Réunion 97427, France
    Recruiting
  • Territorial Health Professional Community (CPTS) Grand Sud
    Saint-Philippe, 97442, Reunion
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06477900
Lead sponsor
Centre Hospitalier Universitaire de la Réunion
Responsible party
Sponsor
First posted
Jun 27, 2024
Start date
Jan 22, 2025
Primary completion
Jan 22, 2028 (estimated)
Completion
Nov 2028 (estimated)
Last update
Mar 19, 2026

Study contacts

Benedicte ARTARIT
Contact
benedicte.artarit@chu-reunion.fr
+262262905284
LERUSTE Sebastien, Dr
principal investigator · Réunion Island University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Prediabetic State →

Other studies from this sponsor

Centre Hospitalier Universitaire de la Réunion →

Start the discussion